Inventor
YONGLI SU
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes26%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
C07DHeterocyclic compounds21%
C07CAcyclic or carbocyclic compounds16%
C07BGeneral methods of organic chemistry5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
PatentTitleYear
12,226,425Inhibitors of ARG1 and/or ARG2202512,103,907Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha202411,945,785Pyrazine compounds as inhibitors of FLT3202411,787,762Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2alpha202311,407,712Tetralin and tetrahydroquinoline compounds as inhibitors of HIF-2a2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ARCUS BIOSCIENCES INC (4)· patent assignee history
2022–2025Based in US· patent location history
2024Patents assigned to BIOMEA FUSION INC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ARCUS BIOSCIENCES INC | 4 | 2022–2025 |
| BIOMEA FUSION INC | 1 | 2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2022–2025 |